Literature DB >> 10467162

Mutational analysis of the regulatory mechanism of PKN: the regulatory region of PKN contains an arachidonic acid-sensitive autoinhibitory domain.

C Yoshinaga1, H Mukai, M Toshimori, M Miyamoto, Y Ono.   

Abstract

PKN is a fatty acid- and Rho GTPase-activated protein kinase whose catalytic domain in the carboxyl terminus is homologous to those of protein kinase C (PKC) family members. The amino terminal region of PKN is suggested to function as a regulatory domain, since tryptic cleavage or the binding of Rho GTPase to this region results in protein kinase activation of PKN. The structural basis for the regulation of PKN was investigated by analyzing the activity of a series of deletion/site-directed mutants expressed in insect cells. The amino-terminally truncated form of PKN (residue 455-942) showed low basal activity similar to that of the wild-type enzyme, and was arachidonic acid-dependent. However, further deletion (residue 511-942) resulted in a marked increase in the basal activity and a decrease in the arachidonic acid dependency. A (His)(6)-tagged protein comprising residues 455-511 of PKN (designated His-Ialpha) inhibited the kinase activity of the catalytic fragment of PKN in a concentration-dependent manner in competition with substrate (K(i) = 0.6+/-0.2 microM). His-Ialpha also inhibited the activity of the catalytic fragment of PRK2, an isoform of PKN, but had no inhibitory effect on protein kinase A or protein kinase Cdelta. The IC(50) value obtained in the presence of 40 microM arachidonic acid was two orders of magnitude greater than that in the absence of the modifier. These results indicate that this protein fragment functions as a specific inhibitor of PKN and PRK2, and that arachidonic acid relieves the catalytic activity of wild-type PKN from autoinhibition by residues 455-511 of PKN. Autophosphorylation of wild-type PKN increased the protein kinase activity, however, substitution of Thr64, Ser374, or Thr531 in the regulatory region of PKN with alanine, abolished this effect. Substitution of Thr774 in the activation loop of the catalytic domain of PKN with alanine completely abolished the protein kinase activity. These results suggest that these phosphorylation sites are also important in the regulation of the PKN kinase activity. Potential differences in the mechanism of activation between the catalytic regions of PKN and PRK2 are also discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10467162     DOI: 10.1093/oxfordjournals.jbchem.a022476

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  22 in total

Review 1.  Rho GTPases and their effector proteins.

Authors:  A L Bishop; A Hall
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

2.  The insert region of RhoA is essential for Rho kinase activation and cellular transformation.

Authors:  H Zong; K Kaibuchi; L A Quilliam
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

3.  Regulation of gene expression by the small GTPase Rho through the ERK6 (p38 gamma) MAP kinase pathway.

Authors:  M J Marinissen; M Chiariello; J S Gutkind
Journal:  Genes Dev       Date:  2001-03-01       Impact factor: 11.361

4.  Characterization of the novel cardiolipin binding regions identified on the protease and lipid activated PKC-related kinase 1.

Authors:  Jason L J Lin
Journal:  Protein Sci       Date:  2019-06-19       Impact factor: 6.725

5.  Identification of an interaction between the TPalpha and TPbeta isoforms of the human thromboxane A2 receptor with protein kinase C-related kinase (PRK) 1: implications for prostate cancer.

Authors:  Elizebeth C Turner; David J Kavanagh; Eamon P Mulvaney; Caitriona McLean; Katarina Wikström; Helen M Reid; B Therese Kinsella
Journal:  J Biol Chem       Date:  2011-02-28       Impact factor: 5.157

6.  Selective matrix (hyaluronan) interaction with CD44 and RhoGTPase signaling promotes keratinocyte functions and overcomes age-related epidermal dysfunction.

Authors:  Lilly Y W Bourguignon; Gabriel Wong; Weiliang Xia; Mao-Qiang Man; Walter M Holleran; Peter M Elias
Journal:  J Dermatol Sci       Date:  2013-06-05       Impact factor: 4.563

7.  Regulation of protein kinase C-related protein kinase 2 (PRK2) by an intermolecular PRK2-PRK2 interaction mediated by Its N-terminal domain.

Authors:  Angelika F Bauer; Silvina Sonzogni; Lucas Meyer; Stefan Zeuzem; Albrecht Piiper; Ricardo M Biondi; Sonja Neimanis
Journal:  J Biol Chem       Date:  2012-04-16       Impact factor: 5.157

Review 8.  Single cell pattern formation and transient cytoskeletal arrays.

Authors:  William M Bement; George von Dassow
Journal:  Curr Opin Cell Biol       Date:  2013-10-23       Impact factor: 8.382

9.  Development of an intracellularly acting inhibitory peptide selective for PKN.

Authors:  Kazuhiro Shiga; Kentaro Takayama; Shiroh Futaki; Jessica E Hutti; Lewis C Cantley; Katsuko Ueki; Yoshitaka Ono; Hideyuki Mukai
Journal:  Biochem J       Date:  2009-12-23       Impact factor: 3.857

10.  A rho-binding protein kinase C-like activity is required for the function of protein kinase N in Drosophila development.

Authors:  Martha Betson; Jeffrey Settleman
Journal:  Genetics       Date:  2007-05-16       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.